» Articles » PMID: 16687931

Genetically Engineered Human Cancer Models Utilizing Mammalian Transgene Expression

Overview
Journal Cell Cycle
Specialty Cell Biology
Date 2006 May 12
PMID 16687931
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer models are vital to cancer biology research, and multiple cancer models are currently available that utilize either murine or human cells, each with particular strengths and weaknesses. The ability to transform primary human cells into tumors through the expression of specific transgenes offers many advantages as a cancer model, including genetic malleability and the ability to transform specific cell types. Until recently, the conversion of primary human cells into tumors through transgene expression required the use of viral genetic elements, which unfortunately adds uncertainty regarding which cancer pathways are affected and how they are affected. In recent years multiple reports have described the transformation of primary human cells into tumors using only mammalian transgenes. This review focuses on these five cancer models, comparing the different cell types which were transformed into tumors and which transgenes were expressed, as well as the cancer pathways affected in the disparate models. These genetically-engineered human cancer models offer a valuable tool to complement existing cancer models and further cancer research.

Citing Articles

Patient-derived tumor models: a more suitable tool for pre-clinical studies in colorectal cancer.

Rizzo G, Bertotti A, Leto S, Vetrano S J Exp Clin Cancer Res. 2021; 40(1):178.

PMID: 34074330 PMC: 8168319. DOI: 10.1186/s13046-021-01970-2.


Quantitative mapping of the cellular small RNA landscape with AQRNA-seq.

Hu J, Yim D, Ma D, Huber S, Davis N, Bacusmo J Nat Biotechnol. 2021; 39(8):978-988.

PMID: 33859402 PMC: 8355021. DOI: 10.1038/s41587-021-00874-y.


Exercise inhibits tumor growth and central carbon metabolism in patient-derived xenograft models of colorectal cancer.

Lu M, Sanderson S, Zessin A, Ashcraft K, Jones L, Dewhirst M Cancer Metab. 2018; 6:14.

PMID: 30473788 PMC: 6237036. DOI: 10.1186/s40170-018-0190-7.


Ras Post-transcriptionally Enhances a Pre-malignantly Primed EMT to Promote Invasion.

Bisogno L, Friedersdorf M, Keene J iScience. 2018; 4:97-108.

PMID: 30240757 PMC: 6147080. DOI: 10.1016/j.isci.2018.05.011.


Analysis of post-transcriptional regulation during cancer progression using a donor-derived isogenic model of tumorigenesis.

Bisogno L, Keene J Methods. 2017; 126:193-200.

PMID: 28529064 PMC: 6489129. DOI: 10.1016/j.ymeth.2017.05.012.